25 XP   0   0   10

Cansino Biologics Inc
Buy, Hold or Sell?

Let's analyse Cansino Biologics Inc together

PenkeI guess you are interested in Cansino Biologics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cansino Biologics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Cansino Biologics Inc

I send you an email if I find something interesting about Cansino Biologics Inc.

Quick analysis of Cansino Biologics Inc (30 sec.)










What can you expect buying and holding a share of Cansino Biologics Inc? (30 sec.)

How much money do you get?

How much money do you get?
¥0.54
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥29.28
Expected worth in 1 year
¥8.23
How sure are you?
66.7%

+ What do you gain per year?

Total Gains per Share
¥-17.15
Return On Investment
-34.6%

For what price can you sell your share?

Current Price per Share
¥49.55
Expected price per share
¥44.02 - ¥60.20
How sure are you?
50%

1. Valuation of Cansino Biologics Inc (5 min.)




Live pricePrice per Share (EOD)

¥49.55

Intrinsic Value Per Share

¥-160.29 - ¥-121.77

Total Value Per Share

¥-131.01 - ¥-92.49

2. Growth of Cansino Biologics Inc (5 min.)




Is Cansino Biologics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$1b$1.1b-$180.2m-18.0%

How much money is Cansino Biologics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$125.8m$264.9m-$390.8m-310.5%
Net Profit Margin-88.2%44.5%--

How much money comes from the company's main activities?

3. Financial Health of Cansino Biologics Inc (5 min.)




What can you expect buying and holding a share of Cansino Biologics Inc? (5 min.)

Welcome investor! Cansino Biologics Inc's management wants to use your money to grow the business. In return you get a share of Cansino Biologics Inc.

What can you expect buying and holding a share of Cansino Biologics Inc?

First you should know what it really means to hold a share of Cansino Biologics Inc. And how you can make/lose money.

Speculation

The Price per Share of Cansino Biologics Inc is ¥49.55. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cansino Biologics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cansino Biologics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥29.28. Based on the TTM, the Book Value Change Per Share is ¥-5.26 per quarter. Based on the YOY, the Book Value Change Per Share is ¥10.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.98 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cansino Biologics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.51-1.0%-0.51-1.0%1.072.2%0.030.1%0.020.0%
Usd Book Value Change Per Share-0.73-1.5%-0.73-1.5%1.392.8%0.731.5%0.681.4%
Usd Dividend Per Share0.130.3%0.130.3%0.010.0%0.030.1%0.030.1%
Usd Total Gains Per Share-0.59-1.2%-0.59-1.2%1.392.8%0.761.5%0.701.4%
Usd Price Per Share20.21-20.21-41.46-22.69-18.91-
Price to Earnings Ratio-39.73--39.73-38.72--46.88--39.07-
Price-to-Total Gains Ratio-34.06--34.06-29.76-5.51-5.51-
Price to Book Ratio4.99-4.99-8.67-5.78-4.82-
Price-to-Total Gains Ratio-34.06--34.06-29.76-5.51-5.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.85772
Number of shares145
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.130.03
Usd Book Value Change Per Share-0.730.73
Usd Total Gains Per Share-0.590.76
Gains per Quarter (145 shares)-86.05110.92
Gains per Year (145 shares)-344.19443.69
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
178-422-35418425434
2157-845-69837851878
3235-1267-10425512761322
4313-1690-13867317021766
5391-2112-17309121272210
6470-2535-207411025522654
7548-2957-241812829783098
8626-3380-276214634033542
9704-3802-310616538293986
10783-4225-345018342544430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.05.00.016.7%1.05.00.016.7%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%4.02.00.066.7%4.02.00.066.7%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%4.02.00.066.7%4.02.00.066.7%

Fundamentals of Cansino Biologics Inc

About Cansino Biologics Inc

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. In addition, it develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. Further, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CS-2023 to treat meningitis; CS-2028 for treating multivalent conjugate vaccine; CS-2032 for hingles; CS-2036 to treat polio; CS-2047 for treating tetanus; and CS-2201 DTcP for combination vaccine. CanSino Biologics Inc. was incorporated in 2009 and is headquartered in Tianjin, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-03-28 03:59:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Cansino Biologics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cansino Biologics Inc earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Cansino Biologics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -88.2% means that ¥-0.88 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cansino Biologics Inc:

  • The MRQ is -88.2%. The company is making a huge loss. -2
  • The TTM is -88.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-88.2%TTM-88.2%0.0%
TTM-88.2%YOY44.5%-132.7%
TTM-88.2%5Y-3,425.7%+3,337.5%
5Y-3,425.7%10Y-2,854.8%-571.0%
1.1.2. Return on Assets

Shows how efficient Cansino Biologics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cansino Biologics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -7.9% Return on Assets means that Cansino Biologics Inc generated ¥-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cansino Biologics Inc:

  • The MRQ is -7.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.9%TTM-7.9%0.0%
TTM-7.9%YOY16.1%-24.1%
TTM-7.9%5Y-4.8%-3.2%
5Y-4.8%10Y-5.2%+0.4%
1.1.3. Return on Equity

Shows how efficient Cansino Biologics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cansino Biologics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -13.5% Return on Equity means Cansino Biologics Inc generated ¥-0.13 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cansino Biologics Inc:

  • The MRQ is -13.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -13.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.5%TTM-13.5%0.0%
TTM-13.5%YOY23.9%-37.4%
TTM-13.5%5Y-6.9%-6.6%
5Y-6.9%10Y-7.5%+0.6%

1.2. Operating Efficiency of Cansino Biologics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cansino Biologics Inc is operating .

  • Measures how much profit Cansino Biologics Inc makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cansino Biologics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -146.9% means the company generated ¥-1.47  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cansino Biologics Inc:

  • The MRQ is -146.9%. The company is operating very inefficient. -2
  • The TTM is -146.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-146.9%TTM-146.9%0.0%
TTM-146.9%YOY41.5%-188.4%
TTM-146.9%5Y-4,008.5%+3,861.6%
5Y-4,008.5%10Y-3,340.4%-668.1%
1.2.2. Operating Ratio

Measures how efficient Cansino Biologics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 3.59 means that the operating costs are ¥3.59 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Cansino Biologics Inc:

  • The MRQ is 3.586. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.586. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.586TTM3.5860.000
TTM3.586YOY0.882+2.703
TTM3.5865Y60.106-56.520
5Y60.10610Y50.089+10.018

1.3. Liquidity of Cansino Biologics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cansino Biologics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.64 means the company has ¥2.64 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Cansino Biologics Inc:

  • The MRQ is 2.643. The company is able to pay all its short-term debts. +1
  • The TTM is 2.643. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.643TTM2.6430.000
TTM2.643YOY3.247-0.604
TTM2.6435Y5.604-2.961
5Y5.60410Y5.300+0.304
1.3.2. Quick Ratio

Measures if Cansino Biologics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cansino Biologics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.17 means the company can pay off ¥1.17 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cansino Biologics Inc:

  • The MRQ is 1.165. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.165. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.165TTM1.1650.000
TTM1.165YOY0.868+0.297
TTM1.1655Y1.982-0.817
5Y1.98210Y2.250-0.268

1.4. Solvency of Cansino Biologics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cansino Biologics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cansino Biologics Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.37 means that Cansino Biologics Inc assets are financed with 36.8% credit (debt) and the remaining percentage (100% - 36.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cansino Biologics Inc:

  • The MRQ is 0.368. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.368. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.368TTM0.3680.000
TTM0.368YOY0.280+0.088
TTM0.3685Y0.259+0.110
5Y0.25910Y0.265-0.007
1.4.2. Debt to Equity Ratio

Measures if Cansino Biologics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cansino Biologics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 62.6% means that company has ¥0.63 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cansino Biologics Inc:

  • The MRQ is 0.626. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.626. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.626TTM0.6260.000
TTM0.626YOY0.416+0.210
TTM0.6265Y0.390+0.236
5Y0.39010Y0.396-0.006

2. Market Valuation of Cansino Biologics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Cansino Biologics Inc generates.

  • Above 15 is considered overpriced but always compare Cansino Biologics Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -39.73 means the investor is paying ¥-39.73 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cansino Biologics Inc:

  • The EOD is -13.482. Based on the earnings, the company is expensive. -2
  • The MRQ is -39.731. Based on the earnings, the company is expensive. -2
  • The TTM is -39.731. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.482MRQ-39.731+26.249
MRQ-39.731TTM-39.7310.000
TTM-39.731YOY38.719-78.450
TTM-39.7315Y-46.881+7.150
5Y-46.88110Y-39.068-7.814
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cansino Biologics Inc:

  • The EOD is -4.139. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -12.196. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.196. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.139MRQ-12.196+8.058
MRQ-12.196TTM-12.1960.000
TTM-12.196YOY91.350-103.547
TTM-12.1965Y-9.184-3.013
5Y-9.18410Y-7.653-1.531
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cansino Biologics Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Cansino Biologics Inc:

  • The EOD is 1.692. Based on the equity, the company is underpriced. +1
  • The MRQ is 4.987. Based on the equity, the company is fair priced.
  • The TTM is 4.987. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.692MRQ4.987-3.295
MRQ4.987TTM4.9870.000
TTM4.987YOY8.672-3.685
TTM4.9875Y5.781-0.795
5Y5.78110Y4.818+0.964
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Cansino Biologics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---5.263-5.2630%10.010-153%5.300-199%4.880-208%
Book Value Per Share--29.28129.2810%34.544-15%19.453+51%16.675+76%
Current Ratio--2.6432.6430%3.247-19%5.604-53%5.300-50%
Debt To Asset Ratio--0.3680.3680%0.280+31%0.259+42%0.265+39%
Debt To Equity Ratio--0.6260.6260%0.416+50%0.390+60%0.396+58%
Dividend Per Share--0.9750.9750%0.057+1611%0.228+328%0.197+396%
Eps---3.675-3.6750%7.736-148%0.224-1740%0.138-2773%
Free Cash Flow Per Share---11.973-11.9730%3.279-465%-2.855-76%-2.565-79%
Free Cash Flow To Equity Per Share---8.520-8.5200%9.558-189%4.105-308%3.606-336%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---121.771--------
Intrinsic Value_10Y_min---160.289--------
Intrinsic Value_1Y_max---4.882--------
Intrinsic Value_1Y_min---7.034--------
Intrinsic Value_3Y_max---20.246--------
Intrinsic Value_3Y_min---29.079--------
Intrinsic Value_5Y_max---42.338--------
Intrinsic Value_5Y_min---59.662--------
Market Cap5687299450.000-535%36132634251.98036132634251.9800%74123617245.450-51%40565946642.464-11%33804955535.387+7%
Net Profit Margin---0.882-0.8820%0.445-298%-34.257+3784%-28.548+3137%
Operating Margin---1.469-1.4690%0.415-454%-40.085+2629%-33.404+2174%
Operating Ratio--3.5863.5860%0.882+306%60.106-94%50.089-93%
Pb Ratio1.692-195%4.9874.9870%8.672-42%5.781-14%4.818+4%
Pe Ratio-13.482+66%-39.731-39.7310%38.719-203%-46.881+18%-39.068-2%
Price Per Share49.550-195%146.020146.0200%299.550-51%163.936-11%136.613+7%
Price To Free Cash Flow Ratio-4.139+66%-12.196-12.1960%91.350-113%-9.184-25%-7.653-37%
Price To Total Gains Ratio-11.556+66%-34.055-34.0550%29.755-214%5.511-718%5.511-718%
Quick Ratio--1.1651.1650%0.868+34%1.982-41%2.250-48%
Return On Assets---0.079-0.0790%0.161-149%-0.048-40%-0.052-34%
Return On Equity---0.135-0.1350%0.239-156%-0.069-49%-0.075-45%
Total Gains Per Share---4.288-4.2880%10.067-143%5.527-178%5.077-184%
Usd Book Value--1002791316.8001002791316.8000%1183027145.600-15%659812948.640+52%563853248.667+78%
Usd Book Value Change Per Share---0.728-0.7280%1.385-153%0.733-199%0.675-208%
Usd Book Value Per Share--4.0534.0530%4.781-15%2.692+51%2.308+76%
Usd Dividend Per Share--0.1350.1350%0.008+1611%0.032+328%0.027+396%
Usd Eps---0.509-0.5090%1.071-148%0.031-1740%0.019-2773%
Usd Free Cash Flow---410025500.800-410025500.8000%112300666.400-465%-95850387.040-77%-85461907.733-79%
Usd Free Cash Flow Per Share---1.657-1.6570%0.454-465%-0.395-76%-0.355-79%
Usd Free Cash Flow To Equity Per Share---1.179-1.1790%1.323-189%0.568-308%0.499-336%
Usd Market Cap787122243.880-535%5000756580.4745000756580.4740%10258708626.770-51%5614327015.317-11%4678605846.098+7%
Usd Price Per Share6.858-195%20.20920.2090%41.458-51%22.689-11%18.907+7%
Usd Profit---125865250.400-125865250.4000%264951576.000-148%8671424.320-1551%5739540.267-2293%
Usd Revenue--142696074.400142696074.4000%595078756.800-76%148258522.772-4%123548768.977+15%
Usd Total Gains Per Share---0.593-0.5930%1.393-143%0.765-178%0.703-184%
 EOD+3 -5MRQTTM+0 -0YOY+7 -285Y+11 -2410Y+14 -21

3.2. Fundamental Score

Let's check the fundamental score of Cansino Biologics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-13.482
Price to Book Ratio (EOD)Between0-11.692
Net Profit Margin (MRQ)Greater than0-0.882
Operating Margin (MRQ)Greater than0-1.469
Quick Ratio (MRQ)Greater than11.165
Current Ratio (MRQ)Greater than12.643
Debt to Asset Ratio (MRQ)Less than10.368
Debt to Equity Ratio (MRQ)Less than10.626
Return on Equity (MRQ)Greater than0.15-0.135
Return on Assets (MRQ)Greater than0.05-0.079
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Cansino Biologics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.094
Ma 20Greater thanMa 5054.280
Ma 50Greater thanMa 10055.804
Ma 100Greater thanMa 20067.181
OpenGreater thanClose49.000
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets11,468,960
Total Liabilities4,223,358
Total Stockholder Equity6,748,090
 As reported
Total Liabilities 4,223,358
Total Stockholder Equity+ 6,748,090
Total Assets = 11,468,960

Assets

Total Assets11,468,960
Total Current Assets7,730,185
Long-term Assets3,738,775
Total Current Assets
Cash And Cash Equivalents 3,394,824
Short-term Investments 2,551,967
Net Receivables 855,490
Inventory 677,777
Other Current Assets 245,044
Total Current Assets  (as reported)7,730,185
Total Current Assets  (calculated)7,725,102
+/- 5,083
Long-term Assets
Property Plant Equipment 3,083,144
Intangible Assets 258,739
Other Assets 398,732
Long-term Assets  (as reported)3,738,775
Long-term Assets  (calculated)3,740,615
+/- 1,840

Liabilities & Shareholders' Equity

Total Current Liabilities2,924,708
Long-term Liabilities1,281,293
Total Stockholder Equity6,748,090
Total Current Liabilities
Short Long Term Debt 1,575,577
Accounts payable 253,120
Other Current Liabilities 636,997
Total Current Liabilities  (as reported)2,924,708
Total Current Liabilities  (calculated)2,465,694
+/- 459,014
Long-term Liabilities
Long term Debt 878,008
Capital Lease Obligations Min Short Term Debt247,045
Other Liabilities 222,355
Deferred Long Term Liability 51,955
Long-term Liabilities  (as reported)1,281,293
Long-term Liabilities  (calculated)1,399,363
+/- 118,070
Total Stockholder Equity
Common Stock247,450
Retained Earnings 42,707
Other Stockholders Equity 121
Total Stockholder Equity (as reported)6,748,090
Total Stockholder Equity (calculated)290,278
+/- 6,457,812
Other
Capital Stock247,450
Common Stock Shares Outstanding 247,450
Net Invested Capital 9,201,675
Net Tangible Assets 6,527,166
Net Working Capital 4,788,120
Property Plant and Equipment Gross 3,401,922



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
> Total Assets 
866,364
795,875
1,784,498
6,748,073
11,874,187
11,468,960
11,468,96011,874,1876,748,0731,784,498795,875866,364
   > Total Current Assets 
426,918
221,004
794,246
5,420,643
9,289,844
7,730,185
7,730,1859,289,8445,420,643794,246221,004426,918
       Cash And Cash Equivalents 
18,247
57,381
202,450
4,447,029
5,456,873
3,394,824
3,394,8245,456,8734,447,029202,45057,38118,247
       Short-term Investments 
402,636
140,000
552,343
666,640
2,326,033
2,551,967
2,551,9672,326,033666,640552,343140,000402,636
       Net Receivables 
2,671
15,129
15
21,639
157,926
855,490
855,490157,92621,6391515,1292,671
       Inventory 
1,624
8,494
16,339
170,512
875,621
677,777
677,777875,621170,51216,3398,4941,624
       Other Current Assets 
1,740
150,676
23,099
114,067
454,494
245,044
245,044454,494114,06723,099150,6761,740
   > Long-term Assets 
439,446
574,871
990,253
1,327,430
2,584,343
3,738,775
3,738,7752,584,3431,327,430990,253574,871439,446
       Property Plant Equipment 
396,894
507,449
589,694
881,914
2,218,305
3,083,144
3,083,1442,218,305881,914589,694507,449396,894
       Intangible Assets 
40,764
51,256
57,215
72,297
198,305
258,739
258,739198,30572,29757,21551,25640,764
       Long-term Assets Other 
3,199
18,152
345,325
0
0
0
000345,32518,1523,199
> Total Liabilities 
259,032
293,558
313,982
677,219
3,326,303
4,223,358
4,223,3583,326,303677,219313,982293,558259,032
   > Total Current Liabilities 
112,927
106,685
116,428
409,468
2,861,417
2,924,708
2,924,7082,861,417409,468116,428106,685112,927
       Short Long Term Debt 
170
239
20,239
40,159
1,080,791
1,575,577
1,575,5771,080,79140,15920,239239170
       Accounts payable 
1,879
6,651
6,171
60,573
842,567
253,120
253,120842,56760,5736,1716,6511,879
       Other Current Liabilities 
94,320
78,311
57,736
142,329
544,437
636,997
636,997544,437142,32957,73678,31194,320
   > Long-term Liabilities 
146,105
186,873
189,687
264,366
451,361
1,281,293
1,281,293451,361264,366189,687186,873146,105
       Long term Debt 
108,333
150,000
130,000
90,000
40,000
878,008
878,00840,00090,000130,000150,000108,333
       Capital Lease Obligations Min Short Term Debt
0
0
16,560
12,378
254,027
247,045
247,045254,02712,37816,56000
       Other Liabilities 
37,772
36,873
59,796
173,961
202,037
222,355
222,355202,037173,96159,79636,87337,772
       Deferred Long Term Liability 
21,310
31,585
52,215
43,371
26,190
51,955
51,95526,19043,37152,21531,58521,310
> Total Stockholder Equity
607,332
502,317
1,470,516
6,070,854
7,995,046
6,748,090
6,748,0907,995,0466,070,8541,470,516502,317607,332
   Common Stock
156,444
160,951
222,650
247,450
247,450
247,450
247,450247,450247,450222,650160,951156,444
   Retained Earnings Total Equity000000
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
8,339
24,119
0
0
0
121
12100024,1198,339



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue499,277
Cost of Revenue-1,148,681
Gross Profit-649,404-649,404
 
Operating Income (+$)
Gross Profit-649,404
Operating Expense-2,345,349
Operating Income-1,846,072-2,994,753
 
Operating Expense (+$)
Research Development690,865
Selling General Administrative565,663
Selling And Marketing Expenses-
Operating Expense2,345,3491,256,528
 
Net Interest Income (+$)
Interest Income96,506
Interest Expense-59,752
Other Finance Cost-489
Net Interest Income36,265
 
Pretax Income (+$)
Operating Income-1,846,072
Net Interest Income36,265
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,993,231-1,846,072
EBIT - interestExpense = -59,752
-1,420,049
-1,360,298
Interest Expense59,752
Earnings Before Interest and Taxes (EBIT)--1,933,480
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-1,993,231
Tax Provision--62,237
Net Income From Continuing Ops-1,930,995-1,930,995
Net Income-1,420,049
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--36,265
 

Technical Analysis of Cansino Biologics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cansino Biologics Inc. The general trend of Cansino Biologics Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cansino Biologics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cansino Biologics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 52.50 < 58.88 < 60.20.

The bearish price targets are: 44.02.

Tweet this
Cansino Biologics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cansino Biologics Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cansino Biologics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cansino Biologics Inc. The current macd is -1.92148387.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cansino Biologics Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cansino Biologics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cansino Biologics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Cansino Biologics Inc Daily Moving Average Convergence/Divergence (MACD) ChartCansino Biologics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cansino Biologics Inc. The current adx is 21.73.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Cansino Biologics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Cansino Biologics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cansino Biologics Inc. The current sar is 54.99.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Cansino Biologics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cansino Biologics Inc. The current rsi is 33.09. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Cansino Biologics Inc Daily Relative Strength Index (RSI) ChartCansino Biologics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cansino Biologics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cansino Biologics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Cansino Biologics Inc Daily Stochastic Oscillator ChartCansino Biologics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cansino Biologics Inc. The current cci is -143.34462958.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Cansino Biologics Inc Daily Commodity Channel Index (CCI) ChartCansino Biologics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cansino Biologics Inc. The current cmo is -44.14490386.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Cansino Biologics Inc Daily Chande Momentum Oscillator (CMO) ChartCansino Biologics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cansino Biologics Inc. The current willr is -86.38888889.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Cansino Biologics Inc Daily Williams %R ChartCansino Biologics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cansino Biologics Inc.

Cansino Biologics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cansino Biologics Inc. The current atr is 2.0883433.

Cansino Biologics Inc Daily Average True Range (ATR) ChartCansino Biologics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cansino Biologics Inc. The current obv is -22,564,441.

Cansino Biologics Inc Daily On-Balance Volume (OBV) ChartCansino Biologics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cansino Biologics Inc. The current mfi is 38.99.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Cansino Biologics Inc Daily Money Flow Index (MFI) ChartCansino Biologics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cansino Biologics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-09MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Cansino Biologics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cansino Biologics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.094
Ma 20Greater thanMa 5054.280
Ma 50Greater thanMa 10055.804
Ma 100Greater thanMa 20067.181
OpenGreater thanClose49.000
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Cansino Biologics Inc with someone you think should read this too:
  • Are you bullish or bearish on Cansino Biologics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cansino Biologics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cansino Biologics Inc

I send you an email if I find something interesting about Cansino Biologics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Cansino Biologics Inc.

Receive notifications about Cansino Biologics Inc in your mailbox!